Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Pregabalin Capsules 75 mg (Cadila Healthcare) versus LYRICA 75 mg (Pfizer) in healthy Thai volunteers under fasting conditions
TCTR20200229001Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of pregabalin (2 arms), sponsored by Bio-innova. Planned start May 2020; status: not yet recruiting.
02
Drugs
pregabalin
Beyond the preview
Go deeper on TCTR20200229001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200229001.